File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Nasopharyngeal carcinoma. Pattern of tumor regression after radiotherapy

TitleNasopharyngeal carcinoma. Pattern of tumor regression after radiotherapy
Authors
Sham, JSTWei, WIKwan, WHChan, CWKwong, WKChoy, D
Issue Date1990
PublisherJohn Wiley & Sons, Inc. The Journal's web site is located at http://www3.interscience.wiley.com/cgi-bin/jhome/28741
Citation
Cancer, 1990, v. 65 n. 2, p. 216-220 How to Cite?
DOI: http://dx.doi.org/10.1002/1097-0142(19900115)65:2<216::AID-CNCR2820650206>3.0.CO;2-Z
AbstractThe primary tumor regression pattern of 50 patients with nasopharyngeal carcinoma was reported. The tumor regression was monitored either by indirect nasopharyngeal mirror examination and biopsy or fiberoptic endoscope and biopsy. Fiberoptic endoscope and biopsy was found to be more accurate in noting residual tumor. It is recommended that booster radiation dose to the residual primary tumors be withheld unless positive biopsy samples persist at 10 or more weeks after radiotherapy.
Persistent Identifierhttp://hdl.handle.net/10722/172617
ISSN
0008-543X
2023 Impact Factor: 6.1
2023 SCImago Journal Rankings: 2.887
ISI Accession Number ID
WOS:A1990CH75100005

 

DC FieldValueLanguage
dc.contributor.authorSham, JSTen_US
dc.contributor.authorWei, WIen_US
dc.contributor.authorKwan, WHen_US
dc.contributor.authorChan, CWen_US
dc.contributor.authorKwong, WKen_US
dc.contributor.authorChoy, Den_US
dc.date.accessioned2012-10-30T06:23:46Z-
dc.date.available2012-10-30T06:23:46Z-
dc.date.issued1990en_US
dc.identifier.citationCancer, 1990, v. 65 n. 2, p. 216-220en_US
dc.identifier.issn0008-543Xen_US
dc.identifier.urihttp://hdl.handle.net/10722/172617-
dc.description.abstractThe primary tumor regression pattern of 50 patients with nasopharyngeal carcinoma was reported. The tumor regression was monitored either by indirect nasopharyngeal mirror examination and biopsy or fiberoptic endoscope and biopsy. Fiberoptic endoscope and biopsy was found to be more accurate in noting residual tumor. It is recommended that booster radiation dose to the residual primary tumors be withheld unless positive biopsy samples persist at 10 or more weeks after radiotherapy.en_US
dc.languageengen_US
dc.publisherJohn Wiley & Sons, Inc. The Journal's web site is located at http://www3.interscience.wiley.com/cgi-bin/jhome/28741en_US
dc.relation.ispartofCanceren_US
dc.subject.meshBiopsyen_US
dc.subject.meshCarcinoma - Pathology - Radiotherapy - Secondaryen_US
dc.subject.meshEndoscopyen_US
dc.subject.meshHumansen_US
dc.subject.meshNasopharyngeal Neoplasms - Pathology - Radiotherapyen_US
dc.subject.meshNeoplasm Recurrence, Localen_US
dc.subject.meshNeoplasm Stagingen_US
dc.subject.meshRadiotherapy Dosageen_US
dc.subject.meshRemission Inductionen_US
dc.titleNasopharyngeal carcinoma. Pattern of tumor regression after radiotherapyen_US
dc.typeArticleen_US
dc.identifier.emailWei, WI: hrmswwi@hku.hken_US
dc.identifier.authorityWei, WI=rp00323en_US
dc.description.naturelink_to_subscribed_fulltexten_US
dc.identifier.doi10.1002/1097-0142(19900115)65:2<216::AID-CNCR2820650206>3.0.CO;2-Zen_US
dc.identifier.pmid2295044-
dc.identifier.scopuseid_2-s2.0-0025015050en_US
dc.identifier.volume65en_US
dc.identifier.issue2en_US
dc.identifier.spage216en_US
dc.identifier.epage220en_US
dc.identifier.isiWOS:A1990CH75100005-
dc.publisher.placeUnited Statesen_US
dc.identifier.scopusauthoridSham, JST=7101655565en_US
dc.identifier.scopusauthoridWei, WI=7403321552en_US
dc.identifier.scopusauthoridKwan, WH=7006610872en_US
dc.identifier.scopusauthoridChan, CW=7404814268en_US
dc.identifier.scopusauthoridKwong, WK=7005955797en_US
dc.identifier.scopusauthoridChoy, D=7102939127en_US
dc.identifier.issnl0008-543X-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats